MSB — Mesoblast Cashflow Statement
0.000.00%
- AU$2.06bn
- AU$2.20bn
- $5.90m
- 43
- 19
- 95
- 54
Annual cashflow statement for Mesoblast, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
C2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 27.3 | 6.21 | 10 | 9.39 | 12.4 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -50.4 | -101 | -65.8 | -63.3 | -48.5 |
Capital Expenditures | -2.1 | -1.65 | -0.157 | -0.264 | -0.271 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1.18 | 0 | -0.075 | 0.07 | 0.174 |
Sale/Maturity of Investment | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.27 | -1.65 | -0.232 | -0.194 | -0.097 |
Financing Cash Flow Items | -12.2 | -7.77 | -11.8 | -11.5 | -11.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 131 | 109 | -9.87 | 74.5 | 40.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 78.9 | 7.55 | -76.4 | 10.9 | -8.36 |